IRCT20120215009014N490招募中3 期
Effect of brimonidine tartrate gel 0.33% versus tretinoin cream 0.05% on post-acne erythema: a single-blind randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Age 18 to 70 years
- •Erythema after acne
排除标准
- •Pregnancy or breastfeeding
- •Taking anti-acne drugs in the last 3 months
- •Contraindications to Brimonirin (including treatment failure, brain failure, depression, blood pressure, scleroderma, Sjogren's syndrome, Raynaud's phenomenon)
研究者
相似试验
尚未招募
3 期
Assessing the effect of brimonidine gel on the redness remained after pimplesIRCT20140212016557N11Shiraz University of Medical Sciences30
已完成
不适用
Efficacy of switching to 0.1% Brimonidine Tartrate in glaucoma patients under combined theraphy.glaucomaJPRN-UMIN000010978Department of Ophthalmology, Yamagata University Medical Hospital.32
进行中（未招募）
1 期
Patient feedback of persistent facial rednessErythema of rosaceaMedDRA version: 20.0 Level: PT Classification code 10039218 Term: Rosacea System Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2012-005686-12-GBGalderma R&D80
进行中（未招募）
不适用
Patient feedback on the treatment of their persistent facial rednessEUCTR2012-005686-12-SEGalderma R&D80
进行中（未招募）
不适用
Patient feedback on the treatment of their persistent facial rednessEUCTR2012-005686-12-DEGalderma R&D80